Načítá se...

Decision-support for treatment with (177)Lu-PSMA: machine learning predicts response with high accuracy based on PSMA-PET/CT and clinical parameters

BACKGROUND: Treatment with radiolabeled ligands to prostate-specific membrane antigen (PSMA) is gaining importance in the treatment of patients with advanced prostate carcinoma. Previous imaging with positron emission tomography/computed tomography (PET/CT) is mandatory. The aim of this study was to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Transl Med
Hlavní autoři: Moazemi, Sobhan, Erle, Annette, Khurshid, Zain, Lütje, Susanne, Muders, Michael, Essler, Markus, Schultz, Thomas, Bundschuh, Ralph A.
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8246232/
https://ncbi.nlm.nih.gov/pubmed/34268431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-6446
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!